PATENT CLAIM ANALYSIS

Application Number: 15753674
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "020800"]

Abstract:
The present invention provides biomaterial compositions that can immobilize HA to the ocular surfaces through an HABpep and transmembrane mucins and collagen of ocular tissues can act as anchoring sites. These biomaterial compositions provide prolonged HA binding and retention in both ex vivo and in vivo animal models. HA eye drop solutions with these the inventive biomaterials can prolong the biological and physical benefits to the ocular surface and potentially be more effective in treating eye disorders including dry eye than standard HA-eye drop presently available. Methods of making and use of the compositions are also provided.

Claim (Index 24):
A method for treatment of a disease or condition of the eye of a subject in need of treatment, comprising administering to the subject an effective amount of the biomaterial composition of  claim 1 , or the pharmaceutical composition of  claim 21 .

Metadata:
- Claim Count in Document: 35.0
- Percentile: 88.0
- Lexical Diversity: 1.44286
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14906111', '14372258', '13728946', '15807034', '14534328']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7671576497425123
- 35 USC 102 Novelty (BERT): 0.5535118987990201
- Combined Prediction Score: 0.7457930746481631
- Mean Citation Score: 323.84721
- Max Citation Score: 446.97955
- Similarity Product: 304.5163970756024

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test